Incross Co.,Ltd. Logo

Incross Co.,Ltd.

A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.

216050 | KO

Overview

Corporate Details

ISIN(s):
KR7216050005
LEI:
Country:
South Korea
Address:
서울특별시 관악구 남부순환로 1926 (경동제약빌딩 5층,8층), 관악구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Incross Co., Ltd. is a digital marketing company specializing in data-driven advertising solutions. The company develops and operates a portfolio of proprietary platforms, including 'Dawin,' a leading video ad network in South Korea, and 'T deal,' an AI-powered commerce service leveraging SK Telecom customer data. Incross also offers 'ASUM,' a big data marketing platform integrating SK Group's advertising businesses, and 'Stellyze,' an AI-based content marketing platform. The firm provides comprehensive services from strategic media planning and campaign execution to performance analysis, supported by its dedicated R&D center and the Incross Data Lab (IDL) for advanced audience insights and targeting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 9.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.0 MB
2025-08-14 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 2.1 KB
2025-08-05 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-08-05 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 109.9 KB
2025-05-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.0 MB
2025-05-08 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.2 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.7 KB
2025-05-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 28.0 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 466.7 KB

Automate Your Workflow. Get a real-time feed of all Incross Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Incross Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Incross Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.